Wednesday, May 22, 2013 Last update: 3:58 AM
Company Tech News as it Breaks
Amplimmune
News articles for Amplimmune:
Monday, January 7, 2013
- Daiichi Sankyo and Amplimmune Announce Strategic Alliance to Develop AMP-110 Therapy for Autoimmune DiseaseTOKYO and GAITHERSBURG, Maryland, Jan. 7, 2013 /PRNewswire/ -- Daiichi Sankyo, Co., Ltd. (hereafter, Daiichi Sankyo) and Amplimmune, Inc. (hereafter, Amplimmune) announced today that they have entered into a broad strategic collaboration to develop a new therapeutic protein, AMP-110 (B7-H4 fusion protein). The collaboration will ... read more